Found: 42
Select item for more details and to access through your institution.
Assessment of bone marrow lymphocytic status during tyrosine kinase inhibitor therapy and its relation to therapy response in chronic myeloid leukaemia.
- Published in:
- Journal of Cancer Research & Clinical Oncology, 2016, v. 142, n. 5, p. 1041, doi. 10.1007/s00432-015-2101-4
- By:
- Publication type:
- Article
Early response evaluation by single cell signaling profiling in acute myeloid leukemia.
- Published in:
- Nature Communications, 2023, v. 14, n. 1, p. 1, doi. 10.1038/s41467-022-35624-4
- By:
- Publication type:
- Article
Variability gene effects of DNA polymorphisms at the apo B, apo AI/C III and apo E loci on serum lipids: the Cardiovascular Risk in Young Finns Study.
- Published in:
- Clinical Genetics, 1994, v. 45, n. 3, p. 113, doi. 10.1111/j.1399-0004.1994.tb04007.x
- By:
- Publication type:
- Article
A tumor-homing peptide with a targeting specificity related to lymphatic vessels.
- Published in:
- Nature Medicine, 2002, v. 8, n. 7, p. 751, doi. 10.1038/nm720
- By:
- Publication type:
- Article
Phase 1 study of the protein deubiquitinase inhibitor VLX1570 in patients with relapsed and/or refractory multiple myeloma.
- Published in:
- Investigational New Drugs, 2020, v. 38, n. 5, p. 1448, doi. 10.1007/s10637-020-00915-4
- By:
- Publication type:
- Article
Long‐term follow‐up of VIALE‐A: Venetoclax and azacitidine in chemotherapy‐ineligible untreated acute myeloid leukemia.
- Published in:
- American Journal of Hematology, 2024, v. 99, n. 4, p. 615, doi. 10.1002/ajh.27246
- By:
- Publication type:
- Article
Phase Ib study of sabatolimab (MBG453), a novel immunotherapy targeting TIM‐3 antibody, in combination with decitabine or azacitidine in high‐ or very high‐risk myelodysplastic syndromes.
- Published in:
- American Journal of Hematology, 2024, v. 99, n. 2, p. E32, doi. 10.1002/ajh.27161
- By:
- Publication type:
- Article
Long‐term survival with oral azacitidine for patients with acute myeloid leukemia in first remission after chemotherapy: Updated results from the randomized, placebo‐controlled, phase 3 QUAZAR AML‐001 trial.
- Published in:
- American Journal of Hematology, 2023, v. 98, n. 4, p. E84, doi. 10.1002/ajh.26847
- By:
- Publication type:
- Article
Nucleolin expressed at the cell surface is a marker of endothelial cells in angiogenic blood vessels.
- Published in:
- Journal of Cell Biology, 2003, v. 163, n. 4, p. 871, doi. 10.1083/jcb.200304132
- By:
- Publication type:
- Article
Enlarged Memory T-Cell Pool and Enhanced Th1-Type Responses in Chronic Myeloid Leukemia Patients Who Have Successfully Discontinued IFN-α Monotherapy.
- Published in:
- PLoS ONE, 2014, v. 9, n. 1, p. 1, doi. 10.1371/journal.pone.0087794
- By:
- Publication type:
- Article
Chronic Myeloid Leukemia Patients in Prolonged Remission following Interferon-&agr; Monotherapy Have Distinct Cytokine and Oligoclonal Lymphocyte Profile.
- Published in:
- PLoS ONE, 2011, v. 6, n. 8, p. 1, doi. 10.1371/journal.pone.0023022
- By:
- Publication type:
- Article
Genetics of familial combined hyperlipidemia.
- Published in:
- Current Atherosclerosis Reports, 1999, v. 1, n. 1, p. 79, doi. 10.1007/s11883-999-0053-3
- By:
- Publication type:
- Article
Efficacy of conventional‐dose cytarabine, idarubicin and thioguanine versus intermediate‐dose cytarabine and idarubicin in the induction treatment of acute myeloid leukemia: Long‐term results of the prospective randomized nationwide AML‐2003 study by the Finnish Leukemia Group
- Published in:
- European Journal of Haematology, 2022, v. 109, n. 3, p. 257, doi. 10.1111/ejh.13805
- By:
- Publication type:
- Article
Dasatinib induces fast and deep responses in newly diagnosed chronic myeloid leukaemia patients in chronic phase: clinical results from a randomised phase-2 study ( Nord CML006).
- Published in:
- European Journal of Haematology, 2015, v. 94, n. 3, p. 243, doi. 10.1111/ejh.12423
- By:
- Publication type:
- Article
Imatinib and pegylated IFN- α2b discontinuation in first-line chronic myeloid leukemia patients following a major molecular response.
- Published in:
- European Journal of Haematology, 2014, v. 92, n. 5, p. 413, doi. 10.1111/ejh.12258
- By:
- Publication type:
- Article
Immunoprofiling of patients with chronic myeloid leukemia at diagnosis and during tyrosine kinase inhibitor therapy Rohon et al. In vivo effects of TKIs on immune cells.
- Published in:
- European Journal of Haematology, 2010, v. 85, n. 5, p. 387, doi. 10.1111/j.1600-0609.2010.01501.x
- By:
- Publication type:
- Article
Molecular monitoring and mutation analysis of patients with advanced phase CML and Ph+ ALL receiving dasatinib Olsson-Strömberg et al. Monitoring dasatinib treated patients.
- Published in:
- European Journal of Haematology, 2010, v. 85, n. 5, p. 399, doi. 10.1111/j.1600-0609.2010.01506.x
- By:
- Publication type:
- Article
Characteristics of young men with clustering risk factors for coronary heart disease: The cardiovascular risk in young finns study.
- Published in:
- American Journal of Human Biology, 1997, v. 9, n. 5, p. 565, doi. 10.1002/(SICI)1520-6300(1997)9:5<565::AID-AJHB4>3.0.CO;2-T
- By:
- Publication type:
- Article
MDS-404: Population Pharmacokinetics Modeling and Evaluation of Clinical Efficacy and Safety of Sabatolimab: Dose Selection and Dose-Response Analysis.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2021, v. 21, p. S349, doi. 10.1016/S2152-2650(21)01810-3
- By:
- Publication type:
- Article
MDS-420: Sabatolimab Plus Hypomethylating Agents (HMAs) in Patients with High-/Very High-risk Myelodysplastic Syndrome (HR/vHR-MDS) and Newly Diagnosed Acute Myeloid Leukemia (ND-AML): Subgroup Analysis of a Phase 1 Study.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2021, v. 21, p. S350, doi. 10.1016/S2152-2650(21)01811-5
- By:
- Publication type:
- Article
Poster: MDS-404: Population Pharmacokinetics Modeling and Evaluation of Clinical Efficacy and Safety of Sabatolimab: Dose Selection and Dose-Response Analysis.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2021, v. 21, p. S230, doi. 10.1016/S2152-2650(21)01448-8
- By:
- Publication type:
- Article
Poster: MDS-420: Sabatolimab Plus Hypomethylating Agents (HMAs) in Patients with High-/Very High-risk Myelodysplastic Syndrome (HR/vHR-MDS) and Newly Diagnosed Acute Myeloid Leukemia (ND-AML): Subgroup Analysis of a Phase 1 Study.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2021, v. 21, p. S230, doi. 10.1016/S2152-2650(21)01447-6
- By:
- Publication type:
- Article
Increased Mutational Burden and Alterations to DNA Damage Repair Genes are Associated With Poor Prognosis and Sensitivity to PI3K-mTOR Inhibitors in Multiple Myeloma.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2017, v. 17, p. e2, doi. 10.1016/j.clml.2017.03.004
- By:
- Publication type:
- Article
Trends in Serum Lipid Levels during 1980–1992 in Children and Young Adults.
- Published in:
- American Journal of Epidemiology, 1997, v. 146, n. 1, p. 64, doi. 10.1093/oxfordjournals.aje.a009192
- By:
- Publication type:
- Article
Clustering of Risk Habits in Young Adults.
- Published in:
- American Journal of Epidemiology, 1995, v. 142, n. 1, p. 36, doi. 10.1093/oxfordjournals.aje.a117543
- By:
- Publication type:
- Article
Tracking and Predictiveness of Serum Lipid and Lipoprotein Measurements in Childhood: A 12-year Follow-up.
- Published in:
- American Journal of Epidemiology, 1994, v. 140, n. 12, p. 1096
- By:
- Publication type:
- Article
Effects of Persistent Physical Activity and Inactivity on Coronary Risk Factors in Children and Young Adults The Cardiovascular Risk in Young Finns Study.
- Published in:
- American Journal of Epidemiology, 1994, v. 140, n. 3, p. 195, doi. 10.1093/oxfordjournals.aje.a117239
- By:
- Publication type:
- Article
Early BCR-ABL1 Transcript Decline after 1 Month of Tyrosine Kinase Inhibitor Therapy as an Indicator for Treatment Response in Chronic Myeloid Leukemia.
- Published in:
- PLoS ONE, 2017, v. 12, n. 1, p. 1, doi. 10.1371/journal.pone.0171041
- By:
- Publication type:
- Article
Axitinib effectively inhibits BCR-ABL1(T315I) with a distinct binding conformation.
- Published in:
- Nature, 2015, v. 519, n. 7541, p. 102, doi. 10.1038/nature14119
- By:
- Publication type:
- Article
Bayesian multi-source regression and monocyte-associated gene expression predict BCL-2 inhibitor resistance in acute myeloid leukemia.
- Published in:
- NPJ Precision Oncology, 2021, v. 5, n. 1, p. 1, doi. 10.1038/s41698-021-00209-9
- By:
- Publication type:
- Article
Quantitative scoring of differential drug sensitivity for individually optimized anticancer therapies.
- Published in:
- Scientific Reports, 2014, p. 1, doi. 10.1038/srep05193
- By:
- Publication type:
- Article
Oral Azacitidine (Oral-AZA) in Patients with Acute Myeloid Leukemia (AML) in First Remission after Intensive Chemotherapy (IC): Long-Term Overall Survival (OS) Results from the Phase 3 QUAZAR AML-001 Trial.
- Published in:
- Journal of Oncology Navigation & Survivorship, 2022, v. 13, n. 11, p. 378
- By:
- Publication type:
- Article
Lymphocytosis after treatment with dasatinib in chronic myeloid leukemia: Effects on response and toxicity.
- Published in:
- 2016
- By:
- Publication type:
- journal article
Dasatinib 100 mg Once Daily Minimizes the Occurrence of Pleural Effusion in Patients With Chronic Myeloid Leukemia in Chronic Phase and Efficacy Is Unaffected in Patients who Develop Pleural Effusion.
- Published in:
- Cancer (0008543X), 2010, v. 116, n. 2, p. 377, doi. 10.1002/cncr.24734
- By:
- Publication type:
- Article
Impact of tyrosine kinase inhibitors on patient outcomes in Philadelphia chromosome-positive acute lymphoblastic leukaemia.
- Published in:
- British Journal of Haematology, 2009, v. 145, n. 5, p. 581, doi. 10.1111/j.1365-2141.2009.07666.x
- By:
- Publication type:
- Article
Expression of vascular endothelial growth factor receptor 3 and Tie1 tyrosine kinase receptor on acute leukemia cells.
- Published in:
- Pediatric Blood & Cancer, 2007, v. 48, n. 4, p. 387, doi. 10.1002/pbc.20857
- By:
- Publication type:
- Article
Concordance in measurable residual disease result after first and second induction cycle in acute myeloid leukemia: An outcome- and cost-analysis.
- Published in:
- Frontiers in Oncology, 2022, v. 12, p. 1, doi. 10.3389/fonc.2022.999822
- By:
- Publication type:
- Article
Influence of parental occupation on coronary heart disease risk factors in children. The Cardiovascular Risk in Young Finns Study.
- Published in:
- 1996
- By:
- Publication type:
- journal article
Single-cell transcriptomes identify patient-tailored therapies for selective co-inhibition of cancer clones.
- Published in:
- Nature Communications, 2024, v. 15, n. 1, p. 1, doi. 10.1038/s41467-024-52980-5
- By:
- Publication type:
- Article
Real‐world experience of novel multiple myeloma treatments in a large, single‐center cohort in Finland.
- Published in:
- EJHaem, 2023, v. 4, n. 4, p. 1019, doi. 10.1002/jha2.802
- By:
- Publication type:
- Article
BCR-ABL isoforms associated with intrinsic or acquired resistance to imatinib: more heterogeneous than just ABL kinase domain point mutations?
- Published in:
- Medical Oncology, 2012, v. 29, n. 1, p. 219, doi. 10.1007/s12032-010-9781-z
- By:
- Publication type:
- Article
Chronic myeloid leukemia patients' adherence to peroral tyrosine kinase inhibitors compared with adherence as estimated by their physicians.
- Published in:
- Patient Preference & Adherence, 2014, v. 8, p. 1619, doi. 10.2147/PPA.S70712
- By:
- Publication type:
- Article